ctDNA-NGS Assay (Liquid Biopsy) for Non-Small Cell Lung Cancer: Utility of Plasma Cell-Free DNA and Tissue NGS in Detecting Genetic Mutations

被引：0
|
作者：
Papadakis, A. [1 ]
Kasymjanova, G. [2 ]
Spatz, A. [1 ]
Cohen, V. [2 ]
Pepe, C. [2 ]
Sakr, L. [2 ]
Merza, R. [1 ]
Agulnik, J. [2 ]
机构：
[1] Lady Davis Inst Med Res, Montreal, PQ, Canada
[2] Jewish Gen Hosp, Montreal, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06D.08
引用
收藏
页码：S325 / S325
页数：1
相关论文
共 50 条
  • [1] Cell-Free Tumor DNA (ctDNA) Utility in Detection and Monitoring EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Agulnik, J.
    Kasymjanova, G.
    Papadakis, A.
    Small, D.
    Sakr, L.
    Pepe, C.
    Wang, H.
    Cohen, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1035 - S1035
  • [2] The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
    Zhang, Yi-Chen
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [3] The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
    Yi-Chen Zhang
    Qing Zhou
    Yi-Long Wu
    Journal of Hematology & Oncology, 10
  • [4] Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Agulnik, J.
    Kasymjanova, G.
    Small, D.
    Pepe, C.
    Sakr, L.
    Chong, G.
    Wang, H.
    Papadakis, A.
    Spatz, A.
    Cohen, V.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S378 - S378
  • [5] Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Agulnik, Jason S.
    Papadakis, Andreas I.
    Pepe, Carmela
    Sakr, Lama
    Small, David
    Wang, Hangjun
    Kasymjanova, Goulnar
    Spatz, Alan
    Cohen, Victor
    CURRENT ONCOLOGY, 2022, 29 (02) : 1107 - 1116
  • [6] Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
    Veldore, Vidya H.
    Choughule, Anuradha
    Routhu, Tejaswi
    Mandloi, Nitin
    Noronha, Vanita
    Joshi, Amit
    Dutt, Amit
    Gupta, Ravi
    Vedam, Ramprasad
    Prabhash, Kumar
    LUNG CANCER-TARGETS AND THERAPY, 2018, 9 : 1 - 11
  • [7] A case series of ERBB2 indel driver mutations in non-small cell lung cancer identified by cell-free circulating tumor DNA NGS
    Peled, Nir
    Belilovski-Rozenblum, Anna
    Soussan-Gutman, Lior
    Lee, Christine
    Talasaz, AmirAli
    Lanman, Richard B.
    CANCER RESEARCH, 2016, 76
  • [8] The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients
    Ottestad, Anine Larsen
    Wahl, Sissel G. F.
    Gronberg, Bjorn Henning
    Skorpen, Frank
    Dai, Hong Yan
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 112
  • [9] Clinical Utility of Combined Plasma and Tissue NGS in Patients with Advanced, Treatment-Naive, Non-small Cell Lung Cancer
    Bote de Cabo, H.
    Siringo, M.
    Garcia-Lorenzo, E.
    Castelo, A.
    Conde, E.
    Hernandez, S.
    Lopez-Rios Moreno, F.
    Herrera, M.
    Baena, J.
    Ruano-Dominguez, Y.
    Enguita, A. B.
    Perez, U.
    Paz-Ares, L.
    Zugazagoitia, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S258 - S258
  • [10] Patterns of Tissue NGS Alterations are Associated with ctDNA Shedding in Non Small Cell Lung Cancer Tumors Harboring EGFR Mutations
    Di Lello, A.
    Torri, V.
    Behera, V.
    Wu, S.
    Hines, J. B.
    Bestvina, C. M.
    Thawani, R.
    Dolezal, J. M.
    Chin, J.
    Pezeshk, A.
    Esposito, A.
    Sacco, M.
    Husain, A. N.
    Segal, J.
    Wang, P.
    Vokes, E.
    Garassino, M. C.
    Cameron, R. B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S327 - S328
12345